BridgeMD
A prospective interventional randomized controlled trial to assess the effect of low dose acetylsalicylic acid as a preventive treatment of preeclampsia in pregnant women who underwent frozen embryo transfer
EU CTIS ID: 2024-516816-72-00
What this study is testing
To assess the incidence of pre-eclamspia in women who underwent a frozen embryo transfer treated with 160mg of ASA versus no treatment.
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- - Healthy women from [18 – 43] years-old, planned for a frozen embryo transfer, with natural and modified natural or HRT cycle
- - Who have given their informed consent
- - Who have a confirmed pregnancy at week 6 of amenorrhea.
You likely can't join if
- - Women presenting one risk factor for preeclampsia: multiple pregnancy, history of preeclampsia, BMI > 30, lupus syndrome, preexistent proteinuria, non-treated chronic high blood pressure (>140/90), antiphospholipid antibody syndrome, diabetes (fasting blood sugar >126mg/dl)
- - Contraindication to ASA (at risk of active hemorrhage (like hemophilia, …); at risk of or who have a gastro-duodenal ulcer; at risk or how have a terminal renal or hepatic insufficiency (only if ASA is given at high dose)
- - Already treated with ASA
- - Treatment with anticoagulants or non-steroid anti-inflammatory drugs
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.